NovaBay Pharmaceuticals (NBY) Insider Trading & Ownership $1.04 -0.10 (-8.77%) Closing price 10/17/2025 04:10 PM EasternExtended Trading$1.04 +0.00 (+0.38%) As of 10/17/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$188.98KNumber OfInsiders Selling(Last 12 Months)0 Get NBY Insider Trade Alerts Want to know when executives and insiders are buying or selling NovaBay Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NBY Insider Buying and Selling by Quarter NovaBay Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/8/2025Poplar Point Capital PartnersMajor ShareholderBuy300$0.47$141.00 4/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,538$0.52$2,359.76 4/2/2025Poplar Point Capital PartnersMajor ShareholderBuy917$0.58$531.86 3/31/2025Poplar Point Capital PartnersMajor ShareholderBuy21,654$0.59$12,775.86 3/28/2025Poplar Point Capital PartnersMajor ShareholderBuy49,400$0.61$30,134.00 3/26/2025Poplar Point Capital PartnersMajor ShareholderBuy13,292$0.61$8,108.12 3/24/2025Poplar Point Capital PartnersMajor ShareholderBuy100$0.60$60.00 3/20/2025Poplar Point Capital PartnersMajor ShareholderBuy5,320$0.61$3,245.20 3/18/2025Poplar Point Capital PartnersMajor ShareholderBuy14,000$0.63$8,820.00 3/14/2025Poplar Point Capital PartnersMajor ShareholderBuy25,511$0.63$16,071.93 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/12/2025Poplar Point Capital PartnersMajor ShareholderBuy11,837$0.62$7,338.94 3/10/2025Poplar Point Capital PartnersMajor ShareholderBuy14,645$0.58$8,494.10 3/7/2025Poplar Point Capital PartnersMajor ShareholderBuy102$0.55$56.10 3/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,000$0.58$2,320.00 2/27/2025Poplar Point Capital PartnersMajor ShareholderBuy385$0.61$234.85 2/25/2025Poplar Point Capital PartnersMajor ShareholderBuy25,033$0.62$15,520.46 2/20/2025Poplar Point Capital PartnersMajor ShareholderBuy1,836$0.63$1,156.68 2/18/2025Poplar Point Capital PartnersMajor ShareholderBuy3,222$0.66$2,126.52 2/3/2025Poplar Point Capital PartnersMajor ShareholderBuy2,597$0.64$1,662.08 1/31/2025Poplar Point Capital PartnersMajor ShareholderBuy70,685$0.65$45,945.25 1/27/2025Poplar Point Capital PartnersMajor ShareholderBuy31,703$0.69$21,875.07 (Data available from 1/1/2013 forward) NBY Insider Trading Activity - Frequently Asked Questions Who is on NovaBay Pharmaceuticals' Insider Roster? The list of insiders at NovaBay Pharmaceuticals includes Audrey Kunin, and Poplar Point Capital Partners. Learn more on insiders at NBY. What percentage of NovaBay Pharmaceuticals stock is owned by insiders? 20.10% of NovaBay Pharmaceuticals stock is owned by insiders. Learn more on NBY's insider holdings. Which NovaBay Pharmaceuticals insiders have been buying company stock? The following insider purchased NBY shares in the last 24 months: Poplar Point Capital Partners ($188,977.78). How much insider buying is happening at NovaBay Pharmaceuticals? Insiders have purchased a total of 301,077 NBY shares in the last 24 months for a total of $188,977.78 bought. NovaBay Pharmaceuticals Key ExecutivesMr. Justin M. Hall Esq. (Age 46)President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director Compensation: $364.15kMr. Tommy Law (Age 39)Controller, Interim CFO & Treasurer Compensation: $177.7k More Insider Trading Tools from MarketBeat Related Companies Cadrenal Therapeutics Insider Transactions Passage Bio Insider Transactions MIRA Pharmaceuticals Insider Transactions Moleculin Biotech Insider Transactions Heatwurx Insider Transactions Rallybio Insider Transactions Aytu BioPharma Insider Transactions Clearside Biomedical Insider Transactions Synergy CHC Insider Transactions Cingulate Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry This page (NYSEAMERICAN:NBY) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
